Price movement over the last 24 hours
Bumi Citra Permai Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bumi Citra Permai Tbk trades at Rp61 (market cap 84.37B, 89.95M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 6.9× Bumi Citra Permai Tbk's market cap, and Bumi Citra Permai Tbk is more actively traded (89.95M versus 1.44M). Which is the better fit depends on your goals.
| BCIP | LABS | |
|---|---|---|
Market Cap | 84.37B | 584.6B |
Volume | 89.95M | 1.44M |
Lot | 899.54K | 14.4K |
Turnover | 5.71B | 209.72M |
Average Price | 63.46 | 145.64 |
Value | 5.71B | 209.72M |
Indicative Equilibrium Price | 61 | 146 |
Indicative Equilibrium Volume | 10.63K | 753 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bumi Citra Permai Tbk (the company) was established on 3 May 2000 based on Notaries Deed No. 2 and the deed of establishment was approved by the the Ministry of Justice dated Sep 7, 2000. The Company’s articles of association has been amended several times, most recently by notarial deed No. 9 of Robert Purba, S.H., dated 6 May, 2009, concerning among others, public offering and issue warrant.
Read more on BCIP →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →